Funding Received
$14.1 Million in 2 Rounds from 2 Investors
Most Recent Funding
$5.8 Million Series A on April 11, 2014
Founded:
2008
Headquarters:
San Carlos, CA
Description:
Eiger is a biopharmaceutical company developing new antiviral agents against novel targets in the treatment of hepatitis.
Founders:
Jeffrey Glenn
Categories:
Biotechnology
Website:
http://www.eigerbio.com

Detailed Description

Update

Eiger BioPharmaceuticals is developer of treatments for strains of hepatitis.

Current Team (6)

Update

Past Team (1)

Update

Funding Rounds (2) - $14.1M

Update

Board Members and Advisors (3)

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    PO Box 430

    San Carlos, CA 94070

    USA

News (2)

Update

Images (1)

Update
  • Sqcxmkzwjbzzxvzmwqro